---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-263724"
form_type: "8-K"
ticker: "LBRX"
cik: "0001691082"
company_name: "LB PHARMACEUTICALS INC"
filed_at: "2026-06-09T20:05:22+00:00"
generated_at: "2026-06-09T20:06:09.102255+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# LB Pharma shareholders elect three Class I directors, ratify auditor at annual meeting

## Summary
- Class I directors elected: Robert A. Lenz (20,059,577 for), Rebecca Luse (18,530,680), Ran Nussbaum (18,748,511).
- Broker non-votes of 3,216,636 on each director election.
- Ratification of BDO USA as auditor for FY 2026: 23,275,974 for, 5,490 against, 2,753 abstain.

## SEC filing metadata
- accession: 0001193125-26-263724
- form_type: 8-K
- ticker: LBRX
- cik: 0001691082
- company_name: LB PHARMACEUTICALS INC
- filed_at: 2026-06-09T20:05:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1691082/000119312526263724/0001193125-26-263724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1691082/000119312526263724/d138757d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-263724
- JSON: https://secwatch.observer/filing/0001193125-26-263724.json
- Plain text: https://secwatch.observer/filing/0001193125-26-263724.txt

## Key facts
- Shareholder Votes
  LB PHARMACEUTICALS INC shareholders approved Ratification of the appointment of BDO USA, P.C. as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-03 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-03
  source text: The Company’s stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1691082/000119312526263724/0001193125-26-263724-index.htm
- Shareholder Votes
  LB PHARMACEUTICALS INC shareholders approved Election of Class I Directors to serve three-year terms until 2029 at the 2026-06-03 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-03
  source text: The Company’s stockholders elected the three persons listed below as Class I directors, each to serve a three-year term until the Company’s 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, or until their earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1691082/000119312526263724/0001193125-26-263724-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.